TRIal For Efficacy of Capre on hyperTriglyceridemiA
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether CaPre(TM), given at doses 1.0g or 2.0g for
12 weeks, has an effect on fasting plasma triglycerides in patients with mild to high
hypertriglyceridemia as compared to a placebo.